Pilar Nava-Parada's profile
I'm female
What I do
Clinical Development of immune-based anti-cancer molecules (human monoclonal antibodies, vaccines).
Affiliations
Current affiliations
-
- Position
- Associate Medical Director
- Company
- Large Pharmaceutical Company
Past affiliations
-
- Position
- Immunology Fellow
- Company
- Mayo Clinic, Rochester MN
- Further information
-
- Position
- Onco-Immunology Postdoctoral Fellow
- Company
- Johns Hopkins Medical School. Oncology and Immunology
- Further information
Location
- City:
- None chosen
- Hub:
- None chosen
Interests
Onco-Immunology: T-cell based therapies.
Projects
anti-CTLA4 for Lung Cancer
Publications
-
Nava-Parada P, Emens L. GV-1001, an injectable telomerase peptide vaccine for the treatment of solid cancers. Current opinion in molecular therapeutics (5) , 490-7 (2007) PubMed ID:(17932813)
-
Carbó R, Nava P, Guarner V. Effects of polarizing solution on glucose uptake of rat oxygenated or hypoxic ventricular myocytes. Clinical and experimental pharmacology & physiology (1-2) , 64-71 PubMed ID:(12542456)
-
Nava P, Carbó R, Cumming E, Guarner V. [The intracellular mechanisms of calcium and insulin in the association of arterial hypertension with diabetes] Archivos del Instituto de Cardiología de México (5) , 469-77 PubMed ID:(10640211)
-
Nava P, Carbó R, Guarner V. 17 beta-estradiol modulates effects of insulin-induced changes in vascular contractility. Archivos de cardiología de México (4) , 253-60 PubMed ID:(14959449)
-
Nava P, Carbó R, Guarner V. Coronary and femoral arterial contraction with high glucose, insulin, and glucose-insulin-potassium solution: effects of hypoxia. Heart and vessels (2) , 57-63 PubMed ID:(11833843)
Contact
- email:
- pilarnavamx [ at ] yahoo.com
Pilar Nava-Parada's activity on Nature Network
Entries
There are no recent entries from Pilar Nava-Parada.